scholarly journals Leveraging City Data to Understand the Opioid Epidemic in Philadelphia

2018 ◽  
Vol 10 (1) ◽  
Author(s):  
Lia N. Pizzicato ◽  
Caroline C. Johnson ◽  
Kendra M. Viner

ObjectiveTo match fatal overdose information across city data sources to understand which systems overdose decedents may have interacted with prior to their deathIntroductionPhiladelphia is in the midst of a drug epidemic that killed 702 Philadelphians in 2015, 907 in 2016, and is on trajectory to kill 1,200 in 2017. Opioids are involved in the majority of fatal overdoses, contributing to 80% of overdose deaths in 2016. In 2016, the age-adjusted death rate for opioid-involved overdoses was 40.4 deaths per 100,000 residents, up from 17.9 deaths per 100,000 residents in 2010. Despite the epidemiologic work accomplished to date, gaps in knowledge still exist, especially for vulnerable populations such as those with serious mental illness or those who were ever incarcerated, homeless, or within the juvenile justice system. Matching individuals who died of an overdose across city systems could provide insight into missed opportunities for interventions. Findings will help inform policy for those systems that serve clients at highest risk for overdose.MethodsIndividuals who succumbed to fatal overdoses involving opioids between January 1, 2012 and June 30, 2016 were matched to other city data systems going back to January 1, 2000. Descriptions of city systems that were matched to fatal overdose data is provided in Table 1. Frequencies were calculated to determine the number of individuals who received services or received services in the three years prior to death, as indicated by one of the city systems.ResultsBetween January 1, 2012 and June 30, 2016, 2,163 individuals died from an opioid-involved overdose. Overdose decedents were predominately male (69.1%), between the ages of 25-34 (28.0%), and white, non-Hispanic (63.5%). Heroin was the most common opioid detected in the system found in 67.1% of overdose decedents. In the years prior to death, 75.4% of individuals had received a service provided by a city agency and 61.6% had received a service within the three years immediately prior to death. Overdose decedents utilized the most services from Community Behavioral Health (CBH), a managed care organization providing behavioral health services for Philadelphia’s Medicaid population, both ever (59.5%) and in the three years prior to death (46.2%). Many decedents were also incarcerated within the Department of Prisons with 50.4% ever incarcerated and 27.9% incarcerated in the three years prior to death (Table 2). Additionally, 20.9% and 17.5% of overdose decedents had a positive STD or hepatitis C test, respectively, ever reported to the Department of Public Health (Table 3).ConclusionsThis match of overdose decedents to other city systems highlights missed opportunities to help individuals who struggle with opioid dependence. Historically, Philadelphia has taken a recovery oriented approach to drug use, which focuses on drug treatment, and these data suggest that this approach is not sufficient for preventing subsequent fatal overdose. A harm reduction approach, which seeks to reduce the harms of drug use through interventions such as overdose reversal training and naloxone distribution, needle and syringe exchange, and education on safe injection practices, needs to be prioritized in this epidemic alongside recovery oriented practices.

1996 ◽  
Vol 42 (8) ◽  
pp. 1330-1336 ◽  
Author(s):  
B A Rouse

Abstract National trends in substance abuse are presented: the civilian noninstitutionalized general population; drug-related emergency department episodes; and booked arrestees. Major metropolitan differences are also noted. This study was based on the primary national data systems for these groups: The Substance Abuse and Mental Health Services Administration (SAMHSA) National Household Survey on Drug Abuse, SAMHSA's Drug Abuse Warning Network (DAWN), and the National Institute of Justice Drug Use Forecasting (DUF) system. While the most prevalent drug differed in the three data sources, all three showed recent increases in marijuana. Despite the general decline in drug use seen in the general population, both the number of drug-related cases in the DAWN system and the drug use detected in the DUF arrestees showed recent increases.


Author(s):  
Nathan W Furukawa ◽  
Erin F Blau ◽  
Zach Reau ◽  
David Carlson ◽  
Zachary D Raney ◽  
...  

Abstract Background Persons who inject drugs (PWID) have frequent healthcare encounters related to their injection drug use (IDU) but are often not tested for human immunodeficiency virus (HIV). We sought to quantify missed opportunities for HIV testing during an HIV outbreak among PWID. Methods PWID with HIV diagnosed in 5 Cincinnati/Northern Kentucky counties during January 2017–September 2018 who had ≥1 encounter 12 months prior to HIV diagnosis in 1 of 2 Cincinnati/Northern Kentucky area healthcare systems were included in the analysis. HIV testing and encounter data were abstracted from electronic health records. A missed opportunity for HIV testing was defined as an encounter for an IDU-related condition where an HIV test was not performed and had not been performed in the prior 12 months. Results Among 109 PWID with HIV diagnosed who had ≥1 healthcare encounter, 75 (68.8%) had ≥1 IDU-related encounters in the 12 months before HIV diagnosis. These 75 PWID had 169 IDU-related encounters of which 86 (50.9%) were missed opportunities for HIV testing and occurred among 46 (42.2%) PWID. Most IDU-related encounters occurred in the emergency department (118/169; 69.8%). Using multivariable generalized estimating equations, HIV testing was more likely in inpatient compared with emergency department encounters (adjusted relative risk [RR], 2.72; 95% confidence interval [CI], 1.70–4.33) and at the healthcare system receiving funding for emergency department HIV testing (adjusted RR, 1.76; 95% CI, 1.10–2.82). Conclusions PWID have frequent IDU-related encounters in emergency departments. Enhanced HIV screening of PWID in these settings can facilitate earlier diagnosis and improve outbreak response.


Author(s):  
Mehdi Noroozi ◽  
Peter Higgs ◽  
Azadeh Bayani ◽  
Bahram Armoon ◽  
Ali Nazeri Astaneh ◽  
...  

Abstract Background With increasing frequencies of non-fatal overdose in people who inject drugs (PWID), it is essential to improve our knowledge about associated risk factors for overdose to inform overdose prevention and assistance programs. The aim of present study was to determine the prevalence of non-fatal overdose and the associated risk factors among PWID in Tehran, Iran. Methods Snowball sampling was used to collect data from 465 participants in Tehran using a cross-sectional survey. Consenting participants who reported drug injecting in the past month and were able to speak and comprehend Farsi enough to respond to survey questions were interviewed. The endpoint of interest was non-fatal overdose in the previous 6 months, or answering “Yes” to the question: “In the last six months, have you ever overdosed by accident? (at least once)”. We used STATA v. 14 for this analysis. Statistical significance was defined as p < 0.05 for all analyses. Results Of 465 PWIDs who participated in this study, all were male, and about half had less than a high school education. The prevalence of self-reported non-fatal overdose in the past 6 months was 38% (CI95%: 34, 43%). Our findings indicate that characteristics and behaviors that were associated with an increased risk of experiencing an overdose in the past 6 months were drug use initiation under 22 years (AOR =2.2, P < 0.05), using methamphetamine (AOR =2.8, P < 0.05), and using multiple drugs at the same time (AOR =2.1, P < 0.05). Also, more recent initiates to injecting (< 2 years) had an increased risk of experiencing an overdose in the past 6 months. The odds of experiencing a non-fatal overdose among PWIDs who regularly attended NSP were 0.6 times less than for those who did not attend regularly (OR = 0.6,95% CI: 0.2–0.9). Conclusion Methamphetamine and alcohol use were the most significant association for non-fatal overdose among PWIDs. Our results indicate that intervention and prevention initiatives seeking to reduce overdoses among PWIDs should not only be focused on the primary drug used but also the use of alcohol and poly-drug use.


2003 ◽  
Vol 49 (2) ◽  
pp. 201-230 ◽  
Author(s):  
Richard Dembo ◽  
James Schmeidler

The authors report the results of developing and evaluating a classification of 315 arrested youths processed at the Hillsborough County Juvenile Assessment Center in Tampa, Florida. Cluster analysis of summary measures of nine baseline alcohol/other drug use and self-reported delinquency variables identified four groups of youths: (a) low-level delinquents and drug users, (b) high-level delinquents, (c) hair-test-identified marijuana and cocaine users, and (d) self-reported drug users. The validity of the typology was assessed by comparing the clusters of youths on their(a) educational experiences; (b) delinquency referral history; (c) neglect, abuse, and family problem history; (d) close friends’ problem behavior; and, of particular interest, given the focus of the analyses, (e) emotional/psychological functioning and mental health and substance abuse treatment history. The findings indicate the youths were experiencing overlapping delinquency, alcohol/other drug use, and emotional/psychological problems. The cooccurrence of these problems among youths entering the juvenile justice system extends findings of their co-occurrence reported in studies of incarcerated youths.


2020 ◽  
Vol 32 (5) ◽  
pp. 432-453
Author(s):  
Sofia Huang ◽  
Sheena Gardner ◽  
Kaitlin N. Piper ◽  
Ashley S. Coleman ◽  
Jennifer E. Becan ◽  
...  

Justice-involved youth are at risk for HIV/STIs but do not access services. The complex challenges of improving the delivery of health-related services within juvenile justice (JJ) settings warrant exploration of strategies to close this service gap. This study describes the successes and challenges of utilizing a local change team (LCT) strategy comprising JJ and health agency staff to implement HIV/STI programming in JJ settings, across six counties in six states in the U.S. Five focus groups comprising n = 28 JJ and health agency staff who served as LCT members were conducted. Results demonstrated the structured nature of the collaborative process and strength of commitment among LCT members were necessary for successful implementation of HIV/STI programming. The use of LCTs comprising membership of JJ and (behavioral) health systems has broader applicability to other health and behavioral health issues faced by youth on probation that JJ staff may feel ill equipped to address.


Sign in / Sign up

Export Citation Format

Share Document